Cardiff Oncology, Inc. Common Stock Share Price
NASDAQ: CRDFHealthcare
Live Cardiff Oncology, Inc. Common Stock Share Price Chart
O H L
Cardiff Oncology, Inc. Common Stock Performance Overview
Days Range
▼
$1.29Low
$1.34High
Markets Today
| Previous Close | $1.30 |
|---|---|
| Open | $1.31 |
| Volume | 152,917 |
| Day's Range | $1.29 - $1.34 |
| 52W Range | $0.76 - $3.31 |
| Market Cap | $105.02 M |
Historical Performance
| 1M Returns | +46.71 |
|---|---|
| 3M Returns | +7.44 |
| 6M Returns | -28.18 |
| 1Y Returns | -39.81 |
| 5Y Returns | -81.05 |
| 10Y Returns | NA |
Cardiff Oncology, Inc. Common Stock Fundamentals
| Market Cap | $105.02 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $593.00 K |
| ROE TTM | -0.71 |
| EPS TTM | $-0.59 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.49 |
| EBITDA | $-48.60 M |
| Profit Margin | -7736.26 |
| Market Cap | $105.02 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $593.00 K |
| ROE TTM | -0.71 |
| EPS TTM | $-0.59 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.49 |
| EBITDA | $-48.60 M |
| Profit Margin | -7736.26 |
Cardiff Oncology, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $109.00 K | $121.00 K | $120.00 K | $243.00 K | $41.00 K | $104.00 K |
| Gross Profit + | $109.00 K | $121.00 K | $120.00 K | $243.00 K | $41.00 K | $104.00 K |
| Operating Income | -$14.38 M | -$14.78 M | -$11.97 M | -$7.83 M | -$12.85 M | -$9.62 M |
| EBITDA | -$14.29 M | -$14.68 M | -$11.88 M | -$7.74 M | -$12.76 M | -$9.53 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $93.00 K | $94.00 K | $89.00 K | $88.00 K | $87.00 K | $87.00 K |
| Income Before Tax | -$13.43 M | -$13.94 M | -$11.26 M | -$7.22 M | -$12.35 M | -$9.23 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$13.43 M | -$13.94 M | -$11.26 M | -$7.22 M | -$12.35 M | -$9.23 M |
| Net Profit Margin | -12324.77% | -11523.14% | -9381.67% | -2969.55% | -30109.76% | -8876.92% |
Cardiff Oncology, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $7.00 K | $7.00 K | $7.00 K | $7.00 K | $7.00 K | $7.00 K |
| Reserve & Surplus | -$397.59 M | -$411.54 M | -$422.76 M | -$429.98 M | -$442.42 M | -$451.67 M |
| Non-Current Liabilities | $640.00 K | $464.00 K | $284.00 K | $102.00 K | $0 | $0 |
| Current Liabilities | $13.29 M | $16.67 M | $14.71 M | $16.39 M | $14.46 M | $10.80 M |
| Total Liabilities | $13.93 M | $17.13 M | $14.99 M | $16.50 M | $14.46 M | $10.80 M |
| Fixed Assets | $805.00 K | $743.00 K | $666.00 K | $578.00 K | $491.00 K | $450.00 K |
| Current Assets | $82.71 M | $73.70 M | $61.80 M | $60.13 M | $47.34 M | $35.59 M |
| Total Assets | $84.81 M | $75.74 M | $63.78 M | $61.88 M | $49.17 M | $37.33 M |
Cardiff Oncology, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$13.43 M | -$13.94 M | -$11.26 M | -$7.22 M | -$12.35 M | -$9.23 M |
| Operating Cash Flow | -$12.79 M | -$8.33 M | -$10.83 M | -$5.97 M | -$12.29 M | -$11.77 M |
| Investing Cash Flow | -$14.58 M | -$4.98 M | $10.16 M | $10.75 M | $3.26 M | $12.27 M |
| Financing Cash Flow | $3.00 K | $0 | $25.00 K | $2.55 M | $105.00 K | $149.00 K |
| Change in Cash | -$27.38 M | -$13.31 M | -$649.00 K | $7.33 M | -$8.93 M | $653.00 K |
Cardiff Oncology, Inc. Common Stock Return Calculator
The Cardiff Oncology, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$1,924
Invested Amount$10,000
Est. Returns$-8,076
About Cardiff Oncology, Inc. Common Stock
Cardiff Oncology Inc is a clinical-stage biotechnology company advancing cancer treatments focused on PLK1 inhibition, a validated oncology target with practice-changing potential. Its main asset, onvansertib, is a specific, oral PLK1 inhibitor currently being evaluated in a Phase 2 trial for first-line treatment of RAS-mutated metastatic colorectal cancer (mCRC), addressing a large, underserved patient population with high unmet need. Onvansertib is also under investigation in other PLK1-driven cancers through ongoing investigator-initiated trials and has shown robust single agent clinical activity in hard-to-treat tumors. By targeting tumor vulnerabilities, to overcome treatment resistance and deliver improved clinical outcomes for patients.
Popular Stocks
FAQs
What is the share price of Cardiff Oncology, Inc. Common Stock today?
Cardiff Oncology, Inc. Common Stock (CRDF) share price as of September 18, 2026 is $1.32. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Cardiff Oncology, Inc. Common Stock?
Yes, Indian Investors can invest in the Cardiff Oncology, Inc. Common Stock (CRDF) Share by opening an international trading account with Angel One.
How can I purchase Cardiff Oncology, Inc. Common Stock shares in India?
Purchasing Cardiff Oncology, Inc. Common Stock (CRDF) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Cardiff Oncology, Inc. Common Stock (CRDF) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Cardiff Oncology, Inc. Common Stock?
Yes, you can purchase fractional shares of Cardiff Oncology, Inc. Common Stock (CRDF) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Cardiff Oncology, Inc. Common Stock?
The market capitalization of Cardiff Oncology, Inc. Common Stock on September 18, 2026, is $105.02 M.
In which sector Cardiff Oncology, Inc. Common Stock belongs?
Cardiff Oncology, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Cardiff Oncology, Inc. Common Stock stocks?
In order to invest in Cardiff Oncology, Inc. Common Stock (CRDF) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
